Literature DB >> 33269374

Clinical Significance of CBC and WBC Morphology in the Diagnosis and Clinical Course of COVID-19 Infection.

Olga Pozdnyakova1,2, Nathan T Connell2,3, Elisabeth M Battinelli2,3, Jean M Connors2,3, Geoffrey Fell4, Annette S Kim1,2.   

Abstract

OBJECTIVES: To investigate the clinical significance of numeric and morphologic peripheral blood (PB) changes in coronavirus disease 2019 (COVID-19)-positive patients in predicting the outcome, as well as to compare these changes between critically ill COVID-19-positive and COVID-19-negative patients.
METHODS: The study included 90 COVID-19-positive (51 intensive care unit [ICU] and 39 non-ICU) patients and 30 COVID-19-negative ICU patients. We collected CBC parameters (both standard and research) and PB morphologic findings, which were independently scored by two hematopathologists.
RESULTS: All patients with COVID-19 demonstrated striking numeric and morphologic WBC changes, which were different between mild and severe disease states. More severe disease was associated with significant neutrophilia and lymphopenia, which was intensified in critically ill patients. Abnormal WBC morphology, most pronounced in monocytes and lymphocytes, was associated with more mild disease; the changes were lost with disease progression. Between COVID-19-positive and COVID-19-negative ICU patients, significant differences in morphology-associated research parameters were indicative of changes due to the severe acute respiratory syndrome coronavirus 2 virus, including higher RNA content in monocytes, lower RNA content in lymphocytes, and smaller hypogranular neutrophils.
CONCLUSIONS: Hospitalized patients with COVID-19 should undergo a comprehensive daily CBC with manual WBC differential to monitor for numerical and morphologic changes predictive of poor outcome and signs of disease progression. © American Society for Clinical Pathology, 2020. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  Atypical lymphocytes; CBC research parameters; COVID-19; Coronavirus; Monocytes; Morphology; Peripheral blood; SARS-CoV-2; Vacuolization

Year:  2020        PMID: 33269374     DOI: 10.1093/ajcp/aqaa231

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


  14 in total

1.  A Multimodal Approach for the Risk Prediction of Intensive Care and Mortality in Patients with COVID-19.

Authors:  Vasileios C Pezoulas; Konstantina D Kourou; Costas Papaloukas; Vassiliki Triantafyllia; Vicky Lampropoulou; Eleni Siouti; Maria Papadaki; Maria Salagianni; Evangelia Koukaki; Nikoletta Rovina; Antonia Koutsoukou; Evangelos Andreakos; Dimitrios I Fotiadis
Journal:  Diagnostics (Basel)       Date:  2021-12-28

2.  MPR and NLR as Prognostic Markers in ICU-Admitted Patients with COVID-19 in Jazan, Saudi Arabia.

Authors:  Abdullah A Mobarki; Gasim Dobie; Muhammad Saboor; Aymen M Madkhali; Mohammad S Akhter; Ali Hakamy; Adel Humran; Yousof Hamali; Denise E Jackson; Hassan A Hamali
Journal:  Infect Drug Resist       Date:  2021-11-23       Impact factor: 4.003

3.  Monotypic plasmacytoid cells mimicking lymph node malignancy in the setting of COVID-19 recovery.

Authors:  Mark G Evans; Anthony Crymes; Jennifer L Crombie; Sankha S Basu; Deborah A Dillon; Waihay J Wong
Journal:  Am J Hematol       Date:  2021-11-20       Impact factor: 13.265

4.  Peramivir, an Anti-Influenza Virus Drug, Exhibits Potential Anti-Cytokine Storm Effects.

Authors:  Chen-Xi Zhang; Ye Tu; Xiao-Chen Sun; Da-Gui Chen; Wan-Nian Zhang; Chun-Lin Zhuang; Zhi-Bin Wang; Li Su
Journal:  Front Immunol       Date:  2022-02-28       Impact factor: 7.561

5.  Characterization of Two Heterogeneous Lethal Mouse-Adapted SARS-CoV-2 Variants Recapitulating Representative Aspects of Human COVID-19.

Authors:  Feihu Yan; Entao Li; Tiecheng Wang; Yuanguo Li; Jun Liu; Weiqi Wang; Tian Qin; Rina Su; Hongyan Pei; Shen Wang; Na Feng; Yongkun Zhao; Songtao Yang; Xianzhu Xia; Yuwei Gao
Journal:  Front Immunol       Date:  2022-02-07       Impact factor: 7.561

6.  Laboratory medicine in pandemic of COVID-19.

Authors:  Leida Tandara; Petra Filipi; Daniela Supe Domic; Branka Kresic; Ivo Ivcic; Sanda Stojanovic Stipic; Zana Rubic; Marijan Tandara
Journal:  Biochem Med (Zagreb)       Date:  2022-04-15       Impact factor: 2.313

7.  Procoagulant Microvesicles in COVID-19 Patients: Possible Modulators of Inflammation and Prothrombotic Tendency.

Authors:  Hassan A Hamali; Muhammad Saboor; Gasim Dobie; Aymen M Madkhali; Mohammad S Akhter; Ali Hakamy; Hesham M Al-Mekhlafi; Denise E Jackson; Yahya H Matari; Abdullah A Mobarki
Journal:  Infect Drug Resist       Date:  2022-04-29       Impact factor: 4.177

8.  Study of the Plasma and Buffy Coat in Patients with SARS-CoV-2 Infection-A Preliminary Report.

Authors:  Karla B Peña; Francesc Riu; Josep Gumà; Carmen Guilarte; Berta Pique; Anna Hernandez; Alba Àvila; Sandra Parra; Antoni Castro; Conxita Rovira; Pitter Cueto; Immaculada Vallverdu; David Parada
Journal:  Pathogens       Date:  2021-06-25

9.  Retinal Microcirculation as a Correlate of a Systemic Capillary Impairment After Severe Acute Respiratory Syndrome Coronavirus 2 Infection.

Authors:  Bettina Hohberger; Marion Ganslmayer; Marianna Lucio; Friedrich Kruse; Jakob Hoffmanns; Michael Moritz; Lennart Rogge; Felix Heltmann; Charlotte Szewczykowski; Julia Fürst; Maximilian Raftis; Antonio Bergua; Matthias Zenkel; Andreas Gießl; Ursula Schlötzer-Schrehardt; Paul Lehmann; Richard Strauß; Christian Mardin; Martin Herrmann
Journal:  Front Med (Lausanne)       Date:  2021-07-09

10.  Complete Blood Count Peculiarities in Pregnant SARS-CoV-2-Infected Patients at Term: A Cohort Study.

Authors:  Roxana Covali; Demetra Socolov; Razvan Socolov; Ioana Pavaleanu; Alexandru Carauleanu; Mona Akad; Vasile Lucian Boiculese; Ana Maria Adam
Journal:  Diagnostics (Basel)       Date:  2021-12-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.